X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (204767) 204767
Book Review (23243) 23243
Publication (19029) 19029
Book Chapter (1290) 1290
Conference Proceeding (978) 978
Dissertation (259) 259
Magazine Article (238) 238
Newsletter (196) 196
Book / eBook (145) 145
Web Resource (68) 68
Reference (60) 60
Trade Publication Article (27) 27
Journal / eJournal (18) 18
Government Document (17) 17
Newspaper Article (13) 13
Data Set (8) 8
Paper (5) 5
Streaming Video (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (167876) 167876
animals (110775) 110775
humans (85756) 85756
male (76297) 76297
rats (53809) 53809
female (45337) 45337
pharmacology & pharmacy (38537) 38537
neurosciences (34764) 34764
mice (30640) 30640
dose-response relationship, drug (23218) 23218
rats, sprague-dawley (19795) 19795
adult (19691) 19691
biochemistry & molecular biology (17474) 17474
middle aged (16084) 16084
agonists (15593) 15593
agonist (14554) 14554
rats, wistar (14080) 14080
in vitro techniques (13090) 13090
cells, cultured (12206) 12206
abridged index medicus (11314) 11314
ligands (11204) 11204
time factors (11122) 11122
expression (11036) 11036
receptors (10999) 10999
activation (10812) 10812
aged (9990) 9990
rat (9808) 9808
article (9619) 9619
brain (9404) 9404
adrenergic beta-agonists - pharmacology (9261) 9261
physiology (9067) 9067
analysis (8851) 8851
endocrinology & metabolism (8743) 8743
chemistry, medicinal (8723) 8723
psychiatry (8483) 8483
mice, inbred c57bl (8338) 8338
research (8278) 8278
treatment outcome (8167) 8167
cell biology (8105) 8105
disease models, animal (8028) 8028
neurons (7984) 7984
cell line (7873) 7873
receptor (7803) 7803
clinical neurology (7732) 7732
adrenergic alpha-agonists - pharmacology (7563) 7563
neurons - drug effects (7310) 7310
signal transduction (7170) 7170
structure-activity relationship (7052) 7052
cells (7012) 7012
dopamine (6973) 6973
physiological aspects (6781) 6781
calcium - metabolism (6665) 6665
immunology (6409) 6409
binding (6010) 6010
inhibition (5903) 5903
adolescent (5869) 5869
pharmacology (5851) 5851
signal transduction - drug effects (5792) 5792
serotonin receptor agonists - pharmacology (5714) 5714
rodents (5606) 5606
in-vitro (5541) 5541
proteins (5512) 5512
apoptosis (5484) 5484
double-blind method (5437) 5437
pregnancy (5419) 5419
inflammation (5393) 5393
dopamine agonists - pharmacology (5273) 5273
phosphorylation (5188) 5188
excitatory amino acid agonists - pharmacology (5179) 5179
in-vivo (5178) 5178
isoproterenol - pharmacology (5123) 5123
mice, knockout (5018) 5018
drug interactions (5009) 5009
care and treatment (4981) 4981
antagonists (4951) 4951
health aspects (4919) 4919
kinetics (4899) 4899
serotonin (4863) 4863
behavior, animal - drug effects (4847) 4847
double-blind (4809) 4809
neurons - metabolism (4808) 4808
cardiac & cardiovascular systems (4751) 4751
asthma (4724) 4724
blood pressure - drug effects (4661) 4661
drug therapy (4645) 4645
neurology (4601) 4601
antagonist (4572) 4572
adrenergic beta-agonists - therapeutic use (4567) 4567
asthma - drug therapy (4564) 4564
motor activity - drug effects (4555) 4555
multidisciplinary sciences (4516) 4516
brain - metabolism (4475) 4475
rat-brain (4461) 4461
chemistry, organic (4443) 4443
analysis of variance (4389) 4389
gene expression (4357) 4357
medicine, research & experimental (4321) 4321
binding sites (4293) 4293
cell line, tumor (4289) 4289
respiratory system (4264) 4264
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (108) 108
Online Resources - Online (61) 61
UofT at Mississauga - Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Gerstein Science - Periodical Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UTL at Downsview - May be requested (7) 7
Gerstein Science - Bindery (6) 6
UofT at Scarborough - Stacks (5) 5
New College (Ivey) - Stacks (3) 3
Robarts - Stacks (3) 3
St. Michael's Hospital - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
University College (Laidlaw) - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Storage (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (198229) 198229
German (1749) 1749
French (1513) 1513
Russian (1334) 1334
Japanese (1263) 1263
Chinese (714) 714
Spanish (555) 555
Polish (277) 277
Portuguese (243) 243
Korean (159) 159
Italian (153) 153
Hungarian (96) 96
Czech (91) 91
Danish (89) 89
Swedish (76) 76
Ukrainian (73) 73
Dutch (69) 69
Turkish (50) 50
Norwegian (39) 39
Bulgarian (35) 35
Slovak (23) 23
Finnish (22) 22
Hebrew (21) 21
Romanian (20) 20
Serbian (15) 15
Lithuanian (12) 12
Slovenian (8) 8
Croatian (7) 7
Persian (6) 6
Icelandic (3) 3
Afrikaans (1) 1
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Progress in brain research, ISBN 0444532358, Volume 172., xv, 665 p. [6] p. of plates
This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the... 
Neurochemistry | Neurotransmitters | Dopamine | Serotonin | Neurochimie
Book
1997, Lung biology in health and disease, ISBN 9780824794965, Volume 106, xvi, 443
Book
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 09/2013, Volume 23, Issue 18, pp. 5082 - 5085
Journal Article
Critical Care Medicine, ISSN 0090-3493, 12/2013, Volume 41, Issue 12, pp. e431 - e438
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 905 - 915
Mu-opioid and CB1-cannabinoid agonists produce analgesia; however, adverse effects limit use of drugs in both classes. Additive or synergistic effects... 
Analgesia | Morphine | Marijuana | G-protein | Adenylyl cyclase | CB1 receptors | AGONIST MORPHINE | ACTIVATION | PROTEIN-KINASE | CB1 CANNABINOID RECEPTOR | SYNERGISTIC INTERACTIONS | NEUROSCIENCES | INHIBITION | KAPPA | FULL AGONIST | ADENYLYL-CYCLASE | PHARMACOLOGY & PHARMACY | RAT-BRAIN | Pyrazoles - therapeutic use | Receptor, Cannabinoid, CB2 - agonists | Humans | Analgesics, Opioid - pharmacology | Receptors, Opioid, mu - agonists | Piperidines - pharmacology | Cannabinoid Receptor Agonists - therapeutic use | Recombinant Proteins - antagonists & inhibitors | Piperidines - metabolism | Receptors, Opioid, mu - metabolism | Morpholines - metabolism | Analgesics, Non-Narcotic - metabolism | Drug Inverse Agonism | Mice | Analgesics, Opioid - metabolism | Kinetics | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Analgesics, Opioid - antagonists & inhibitors | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Analgesics, Non-Narcotic - pharmacology | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Analgesics, Opioid - adverse effects | Narcotic Antagonists - metabolism | Receptor, Cannabinoid, CB1 - agonists | Analgesics, Non-Narcotic - adverse effects | Cannabinoid Receptor Agonists - adverse effects | Morpholines - adverse effects | CHO Cells | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Binding, Competitive | Recombinant Proteins - metabolism | Cricetinae | Morpholines - pharmacology | Narcotic Antagonists - adverse effects | Recombinant Proteins - agonists | Analgesics, Non-Narcotic - therapeutic use | Pyrazoles - metabolism | Mice, Inbred Strains | Receptors, Opioid, mu - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Narcotic Antagonists - pharmacology | Piperidines - adverse effects | Receptors, Opioid, mu - genetics | Index Medicus | Drugs | Pain perception | Opioid receptors | Cyclic AMP | Opioid receptors (type mu) | Antagonists | Cannabinoid CB1 receptors | Guanine nucleotide-binding protein | Antagonism | Cell activation | Side effects | Inverse agonists | CB1 Receptors | Adenylyl Cyclase
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 2, pp. 283 - 295
Abstract Background Mirabegron, a β3 -adrenoceptor agonist, has been developed for the treatment of overactive bladder (OAB). Objective To assess the efficacy... 
Urology | Mirabegron | β3-Adrenoceptor agonist | Overactive bladder (OAB) | Adrenoceptor agonist
Journal Article
European Urology, ISSN 0302-2838, 02/2019, Volume 75, Issue 2, pp. 274 - 282
Antimuscarinics have shown modest efficacy with unwanted side effects in patients with overactive bladder (OAB). Efficacy of vibegron, a new β3-adrenergic... 
Urinary frequency | Micturitions | Dry mouth | Urinary urgency | Overactive bladder | Tolterodine | Urge incontinence | β3-Adrenergic receptor agonist | Vibegron | BETA-ADRENOCEPTOR AGONIST | EFFICACY | MIRABEGRON | PERSISTENCE | ADHERENCE | MEDICATION USE | 3-ADRENOCEPTOR AGONIST | TOLERABILITY | UROLOGY & NEPHROLOGY | beta 3-Adrenergic receptor agonist | RECEPTOR AGONIST | EXTENDED-RELEASE | Tolterodine Tartrate - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Pyrrolidines - administration & dosage | Pyrrolidines - adverse effects | Male | Adrenergic beta-3 Receptor Agonists - adverse effects | Recovery of Function | Young Adult | Urinary Bladder, Overactive - drug therapy | Time Factors | Urinary Bladder, Overactive - physiopathology | Urination - drug effects | Adult | Female | Tolterodine Tartrate - adverse effects | Drug Therapy, Combination | Adrenergic beta-3 Receptor Agonists - administration & dosage | Urinary Bladder, Overactive - diagnosis | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidinones - adverse effects | Treatment Outcome | Muscarinic Antagonists - administration & dosage | Adolescent | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Pyrimidinones - administration & dosage | Index Medicus
Journal Article
CNS spectrums, ISSN 1092-8529, 02/2019, Volume 24, Issue 1, pp. 181 - 182
Dopaminergic mechanisms are involved in addiction but few effective drugs have been developed to treat it. Recent research has highlighted dopamine D2 receptor... 
Journal Article
2000, Taylor & Francis series in pharmaceutical sciences, ISBN 0748408045, 189
Introduction - Structure and Function of the ß3-Adrenoreceptor, A.D. Strosberg and C.C. Gerhardt Regulation of the ß3-Adrenoreceptor Signalling Efficacy, M.... 
Adrenergic beta agonists | Beta adrenoceptors
eBook
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, pp. 141 - 147
The histamine H4 receptor (H4R) is expressed primarily on cells involved in inflammation and immune responses. Recently, it has been reported the functional... 
Anxiety | Pain | Histamine H4 receptors | Memory | Central nervous system | Feeding | Histamine | H4 receptors | FOOD-INTAKE | PHARMACOLOGICAL CHARACTERIZATION | MOUSE | RATS | LIGHT/DARK BOX TEST | NEUROSCIENCES | H1 RECEPTORS | NEURONAL HISTAMINE | PHARMACOLOGY & PHARMACY | H-4 RECEPTOR | MOLECULAR-CLONING | ANTAGONISTS | Central Nervous System - metabolism | Receptors, G-Protein-Coupled - metabolism | Motor Activity - drug effects | Guanidines - pharmacology | Male | Receptors, G-Protein-Coupled - agonists | Thiourea - pharmacology | Appetite Depressants - therapeutic use | Histamine Agonists - administration & dosage | Analgesics - agonists | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Nootropic Agents - antagonists & inhibitors | Histamine Antagonists - pharmacology | Behavior, Animal - drug effects | Neurons - metabolism | Anti-Anxiety Agents - therapeutic use | Receptors, Histamine H4 | Neurons - drug effects | Appetite Depressants - chemistry | Guanidines - administration & dosage | Histamine Agonists - therapeutic use | Analgesics - therapeutic use | Nerve Tissue Proteins - antagonists & inhibitors | Nootropic Agents - agonists | Anti-Anxiety Agents - agonists | Nerve Tissue Proteins - agonists | Histamine Antagonists - administration & dosage | Nootropic Agents - therapeutic use | Random Allocation | Thiourea - administration & dosage | Antidepressive Agents - therapeutic use | Nerve Tissue Proteins - metabolism | Receptors, Histamine - metabolism | Animals | Anti-Anxiety Agents - antagonists & inhibitors | Analgesics - antagonists & inhibitors | Receptors, G-Protein-Coupled - antagonists & inhibitors | Central Nervous System - drug effects | Benzimidazoles - pharmacology | Mice | Histamine Agonists - pharmacology | Thiourea - analogs & derivatives | Histamine Agonists - chemistry | Analysis | Diazepam | Index Medicus
Journal Article
NATURE, ISSN 0028-0836, 01/2011, Volume 469, Issue 7329, pp. 175 - 180
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2008, Volume 283, Issue 27, pp. 18493 - 18504
Human platelets express protease-activated receptor 1 (PAR1) and PAR4 but limited data indicate for differences in signal transduction. We studied the... 
Receptor, PAR-1 - metabolism | Humans | Thrombin - antagonists & inhibitors | Receptors, Adrenergic, alpha-2 - metabolism | Secretory Vesicles - metabolism | Hemostatics - pharmacology | Peptide Fragments - pharmacology | Epinephrine - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Epinephrine - agonists | Dose-Response Relationship, Drug | Adrenergic alpha-2 Receptor Agonists | Receptors, Thrombin - agonists | Thrombin - pharmacology | Blood Platelets - cytology | Adenosine Triphosphate - metabolism | Thrombin - agonists | Platelet Aggregation Inhibitors - pharmacology | Platelet Aggregation - drug effects | Aspirin - pharmacology | Aspirin - agonists | Chromones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Aspirin - antagonists & inhibitors | Oligopeptides - antagonists & inhibitors | Calcium - pharmacology | Receptor, PAR-1 - agonists | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Platelet Aggregation - physiology | Purinergic P2 Receptor Agonists | Oligopeptides - agonists | Receptors, Purinergic - metabolism | Receptors, Purinergic P2X | Drug Synergism | Drug Antagonism | Purinergic Agonists | Blood Platelets - metabolism | Peptide Fragments - agonists | Peptide Fragments - antagonists & inhibitors | Receptors, Purinergic P2 - metabolism | Receptors, Thrombin - metabolism | Adrenergic alpha-Agonists - pharmacology | Adenosine Diphosphate - metabolism | Adrenergic alpha-2 Receptor Antagonists | Oligopeptides - pharmacology | Epinephrine - pharmacology | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Annals of Neurology, ISSN 0364-5134, 2008, Volume 64, Issue 1, pp. 42 - 52
Journal Article